Humana Interest Paid decreased by 24.5% to $142.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $143.00M to $142.00M. Over 3 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 30.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $71.25M | $71.25M | $71.25M | $67.00M | $104.00M | $97.00M | $78.00M | $142.00M | $77.00M | $158.00M | $92.00M | $166.00M | $168.00M | $143.00M | $150.00M | $147.00M | $188.00M | $142.00M |
| QoQ Change | — | +0.0% | +0.0% | -6.0% | +55.2% | -6.7% | -19.6% | +82.1% | -45.8% | +105.2% | -41.8% | +80.4% | +1.2% | -14.9% | +4.9% | -2.0% | +27.9% | -24.5% |
| YoY Change | — | — | — | — | +46.0% | +44.8% | -25.0% | — | — | +62.9% | +17.9% | +16.9% | +118.2% | -9.5% | +63.0% | -11.4% | +11.9% | -0.7% |